Gene-editing technique used to fight influenza could 'neutralize' coronavirus


A free daily digest of the biggest news stories of the day - and the best features from our website
Thank you for signing up to TheWeek. You will receive a verification email shortly.
There was a problem. Please refresh the page and try again.
PAC-MAN might be the key to munching our way through the coronavirus pandemic.
Okay, so the ghost-eating yellow blob has nothing to do with stopping a deadly virus. But a gene editing technique that borrows the video game's name could prove effective in "scrambling" COVID-19's genetic code and stopping it from growing, Science Daily reports.
Stanley Qi's bioengineering team at Stanford University started working last year to develop a way to use the CRISPR gene-editing tool to fight influenza, calling their technique "PAC-MAN." It sends a virus-killing enzyme into a virus' RNA — DNA's instructional messenger — that in turn tells the enzyme to attack the virus' genetic material.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The arrival of the novel coronavirus, with no clear cure or treatment, presented a new opportunity for PAC-MAN. "By scrambling the virus's genetic code, PAC-MAN could neutralize the coronavirus and stop it from replicating inside cells," Science Daily writes.
But there was still the dilemma of how to actually deliver the PAC-MAN technique into lung cells. So after publishing a preprint of their study on the technique, Qi's lab found the Biological Nanostructures Facility at Berkeley Lab's Molecular Foundry. The facility focuses on using lipitoids to deliver therapies, and after a first test, the lipitoids "performed very well" at delivering the gene-scrambling treatment, Science Daily writes. Read more at Science Daily.
Continue reading for free
We hope you're enjoying The Week's refreshingly open-minded journalism.
Subscribed to The Week? Register your account with the same email as your subscription.
Sign up to our 10 Things You Need to Know Today newsletter
A free daily digest of the biggest news stories of the day - and the best features from our website
Kathryn is a graduate of Syracuse University, with degrees in magazine journalism and information technology, along with hours to earn another degree after working at SU's independent paper The Daily Orange. She's currently recovering from a horse addiction while living in New York City, and likes to share her extremely dry sense of humor on Twitter.
-
Biden's first rodeo
cartoons
By The Week Staff Published
-
Biden's stumble
Cartoons
By The Week Staff Published
-
The daily gossip: Travis Kelce chats about Taylor Swift's Chiefs game visit, Hollywood writers thrilled with details of new contract as strike ends, and more
The daily gossip: September 27, 2023
By Brendan Morrow Published
-
FDA to re-evaluate effectiveness of common nasal congestion ingredient
Speed Read
By Justin Klawans Published
-
A flesh-eating bacteria is growing in numbers due to climate change
Speed Read
By Devika Rao Published
-
CDC recommends new RSV vaccine for infants under 8 months
Speed Read
By Devika Rao Published
-
U.S. health agency advises easing federal marijuana restrictions
Speed Read
By Peter Weber Published
-
Medicare drug price negotiations start with 1st 10 drugs, pharmaceutical industry lawsuits
Speed Read
By Peter Weber Published
-
Air pollution may be increasing antibiotic resistance, new research suggests
Speed Read
By Devika Rao Published
-
Tick bites could cause an allergy to red meat, CDC says
Speed Read
By Devika Rao Published
-
The danger of drinking too much water
Speed Read
By Devika Rao Published